Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid Withdrawal in Pediatric Renal Transplant Recipients on MMF and Cyclosporine
NCT00309218Phase 3Completed
- Start
- Mar 1999
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mycophenolate mofetil in kidney transplant rejection (2 arms). Primary endpoint: Stimulation of length growth at 36 months. Started Mar 1999; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00309218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309218.